Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

BeyondSpring Inc. (BYSI)

1.7000
-0.4300
(-20.19%)
At close: May 7 at 4:00:00 PM EDT
1.7100
+0.01
+(0.59%)
After hours: May 7 at 7:01:40 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
1,351
1,351
Operating Expense
8,754
8,754
15,081
38,590
67,591
Operating Income
-8,754
-8,754
-15,081
-37,239
-66,240
Net Non Operating Interest Income Expense
59
59
322
178
11
Other Income Expense
-74
-74
836
944
1,591
Pretax Income
-8,769
-8,769
-13,923
-36,117
-64,638
Tax Provision
96
96
92
163
3,570
Net Income Common Stockholders
-11,123
-11,123
-21,026
-33,279
-64,179
Diluted NI Available to Com Stockholders
-11,123
-11,123
-21,026
-33,279
-64,179
Basic EPS
-0.28
--
-0.54
-0.85
-1.64
Diluted EPS
-0.28
--
-0.54
-0.85
-1.64
Basic Average Shares
39,733.1910
--
38,996.4630
39,093.2460
39,023.6430
Diluted Average Shares
39,733.1910
--
38,996.4630
39,093.2460
39,023.6430
Total Operating Income as Reported
-8,754
-8,754
-15,081
-37,239
-66,240
Total Expenses
8,754
8,754
15,081
38,590
67,591
Net Income from Continuing & Discontinued Operation
-11,123
-11,123
-21,026
-33,279
-64,179
Normalized Income
-3,219.1600
-3,219.1600
-12,991.8800
-32,940.0900
-64,347.6300
Interest Income
59
59
322
195
98
Interest Expense
--
--
0
17
87
Net Interest Income
59
59
322
178
11
EBIT
-8,754
-8,754
-15,081
-36,100
-64,551
EBITDA
-8,469
-8,469
-14,779
-35,868
-64,490
Reconciled Depreciation
285
285
302
232
61
Net Income from Continuing Operation Net Minority Interest
-3,295
-3,295
-13,093
-33,279
-64,179
Total Unusual Items Excluding Goodwill
-96
-96
-128
-429
231
Total Unusual Items
-96
-96
-128
-429
231
Normalized EBITDA
-8,373
-8,373
-14,651
-35,439
-64,721
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0003
Tax Effect of Unusual Items
-20.1600
-20.1600
-26.8800
-90.0900
62.3700
12/31/2021 - 3/9/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ALLK Allakos Inc.
0.3277
0.00%
 
INDP Indaptus Therapeutics, Inc.
0.4300
0.00%
 
MLEC Moolec Science SA
0.9161
+20.54%
 
IMRN Immuron Limited
1.8600
0.00%
 
GRTX Galera Therapeutics, Inc.
0.0240
+2.13%
 
FBRX Forte Biosciences, Inc.
6.19
-2.83%
 
NBTX Nanobiotix S.A.
3.3000
-15.17%
 
KZIA Kazia Therapeutics Limited
3.1400
+0.64%
 
BIOR Biora Therapeutics, Inc.
0.2200
0.00%
 
BNTC Benitec Biopharma Inc.
13.54
-2.59%